Geron Announces Conference Call to Discuss First Quarter Financial Results and
Highlights
MENLO PARK, Calif., Apr 25, 2011 (BUSINESS WIRE) -- Geron Corporation (GERN) will
announce its financial results for the first quarter ended March 31, 2011 on
Wednesday, April 27, 2011, after the closing of the equity market. David L.
Greenwood, Geron's President and Chief Executive Officer, will host a conference
call for analysts and investors on Thursday, April 28, 2011 at 8:00 a.m. Pacific
Time, 11:00 a.m. Eastern Time.
Participants can access the conference call live via telephone by dialing
800-573-4840 (U.S.); 617-224-4326 (international). The passcode is 23275594. If
accessing the conference call by telephone, please dial in at least 10 minutes
early to minimize any delay in joining the call. A live audio-only webcast is
also available at
phx.corporate-ir.net.
The audio webcast of the conference call will be available for replay
approximately one hour following the live broadcast through May 30, 2011.
Geron is developing first-in-class biopharmaceuticals for the treatment of cancer
and chronic degenerative diseases. The company is advancing anti-cancer therapies
through multiple Phase 2 clinical trials in different cancers by targeting the
enzyme telomerase and with a compound designed to penetrate the blood-brain
barrier. The company is developing cell therapy products from differentiated
human embryonic stem cells for multiple indications, including central nervous
system (CNS) disorders, heart failure, diabetes and osteoarthritis, and has
initiated a Phase 1 clinical trial in spinal cord injury. For more information,
visit geron.com.
SOURCE: Geron Corporation |
